FR2558060B1 - Nouvelles formes pharmaceutiques contenant des diphosphonates - Google Patents

Nouvelles formes pharmaceutiques contenant des diphosphonates

Info

Publication number
FR2558060B1
FR2558060B1 FR8500255A FR8500255A FR2558060B1 FR 2558060 B1 FR2558060 B1 FR 2558060B1 FR 8500255 A FR8500255 A FR 8500255A FR 8500255 A FR8500255 A FR 8500255A FR 2558060 B1 FR2558060 B1 FR 2558060B1
Authority
FR
France
Prior art keywords
pharmaceutical forms
forms containing
novel pharmaceutical
diphosphonates
containing diphosphonates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8500255A
Other languages
English (en)
French (fr)
Other versions
FR2558060A1 (fr
Inventor
Sergio Rosini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Gentili SpA
Original Assignee
Istituto Gentili SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Gentili SpA filed Critical Istituto Gentili SpA
Publication of FR2558060A1 publication Critical patent/FR2558060A1/fr
Application granted granted Critical
Publication of FR2558060B1 publication Critical patent/FR2558060B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR8500255A 1984-01-12 1985-01-09 Nouvelles formes pharmaceutiques contenant des diphosphonates Expired FR2558060B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT19122/84A IT1195993B (it) 1984-01-12 1984-01-12 Forme farmaceutiche a base di difosfonati

Publications (2)

Publication Number Publication Date
FR2558060A1 FR2558060A1 (fr) 1985-07-19
FR2558060B1 true FR2558060B1 (fr) 1988-02-19

Family

ID=11154925

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8500255A Expired FR2558060B1 (fr) 1984-01-12 1985-01-09 Nouvelles formes pharmaceutiques contenant des diphosphonates

Country Status (4)

Country Link
DE (1) DE3500670A1 (enrdf_load_stackoverflow)
FR (1) FR2558060B1 (enrdf_load_stackoverflow)
GB (1) GB2153225B (enrdf_load_stackoverflow)
IT (1) IT1195993B (enrdf_load_stackoverflow)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten
US5853759A (en) * 1996-05-17 1998-12-29 Merck & Co.. Inc. Effervescent alendronate formulation
WO1997044017A1 (en) * 1996-05-17 1997-11-27 Merck & Co., Inc. Effervescent bisphosphonate formulation
EP1378234A1 (en) * 1996-05-17 2004-01-07 MERCK & CO. INC. Effervescent bisphosphonate formulation
US7488496B2 (en) 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
DK1490024T3 (da) * 2002-03-06 2012-04-10 Effrx Pharmaceuticals Sa Alendronatholdige brusesammensætninger
SI1506041T1 (sl) 2002-05-10 2008-02-29 Hoffmann La Roche Ibandronska kislina za zdravljenje in preprecevanje osteoporoze
CA2484494C (en) 2002-12-20 2009-05-12 F. Hoffmann-La Roche Ag High dose ibandronate formulation
WO2006100527A1 (en) * 2005-03-24 2006-09-28 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Effervescent tablet containing sodium alendronate and related use and process
WO2012078528A2 (en) * 2010-12-06 2012-06-14 Effrx Pharmaceuticals Sa Stable effervescent bisphosphonate formulations with rapid solubilization characteristics

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL283067A (enrdf_load_stackoverflow) *
DE2360797C2 (de) * 1973-12-06 1985-05-23 Henkel KGaA, 4000 Düsseldorf Pharmazeutische Präparate
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
DE2813121A1 (de) * 1977-03-29 1978-10-12 Procter & Gamble Verwendung von dichlormethan-diphosphonatverbindungen bei der bekaempfung von collagen-erkrankungen und zur wundheilung
GB2043072B (en) * 1979-02-13 1983-11-23 Symphar Sa Diphosphonate compounds
GB2079285B (en) * 1980-07-09 1984-05-23 Symphar Sa Dipthosphonate derivatives and pahrmaceutical compositions containing them
IT1194748B (it) * 1981-02-12 1988-09-28 Gentili Ist Spa Composizioni farmaceutiche per il trattamento di osteopatie
DE3225468A1 (de) * 1982-07-05 1984-01-05 Schering AG, 1000 Berlin und 4709 Bergkamen Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate
DE19675047I2 (de) * 1982-04-15 2003-06-12 Gentili Ist Spa Pharmazeutische Zusammensetzung mit einem Gehalt an 4-amino-1-hydroxybutan-1, 1-biphosphonsaeure

Also Published As

Publication number Publication date
GB2153225A (en) 1985-08-21
IT8419122A0 (it) 1984-01-12
DE3500670C2 (enrdf_load_stackoverflow) 1992-01-16
DE3500670A1 (de) 1985-07-18
IT1195993B (it) 1988-11-03
FR2558060A1 (fr) 1985-07-19
GB8500504D0 (en) 1985-02-13
GB2153225B (en) 1987-08-05

Similar Documents

Publication Publication Date Title
MA19503A1 (fr) Nouvelles formes orales de dipyridamole
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
SE8801813L (sv) Pharmaceutical composition
KR890701101A (ko) 제약학적 조성물
FI862479L (fi) Oral farmaceutisk komposition.
FI863362A7 (fi) Farmaseuttinen koostumus.
FR2571966B1 (fr) Compositions therapeutiques contenant des anthracyclines-glucosides.
FI872733A0 (fi) Farmaceutiska kompositioner.
DK164187D0 (da) Plaquemodvirkende oralt middel
FI872313A0 (fi) Farmaceutiska kompositioner.
FR2558060B1 (fr) Nouvelles formes pharmaceutiques contenant des diphosphonates
IT1209615B (it) Composizione farmaceutica
KR860004644A (ko) 탈취장치
DK315088A (da) Plaquemodvirkende oralt middel
MC1878A1 (fr) Compositions pharmaceutiques
DK142487D0 (da) Farmaceutiske midler
FR2609392B1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines
IT1216056B (it) Composizioni farmaceutiche contenenti timosina alfa 1.
MX11584A (es) Composiciones farmaceuticas
DE3577656D1 (de) Pharmazeutische zusammensetzungen von ceftazidim.
IT1216814B (it) Composizioni farmaceutiche
IT1199948B (it) Composizioni farmaceutiche comprendenti la bromocriptina
BE890011A (fr) Nouvelles compositions pharmaceutiques contenant de l'almitrine
IT1203737B (it) Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli
IT1215261B (it) Composizioni farmaceutiche adattivita' antigalattopoietica.